These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7284925)

  • 1. Bacteroides fragilis septicemia during cefamandole therapy.
    Righter J
    Can Med Assoc J; 1981 Sep; 125(5):422, 424. PubMed ID: 7284925
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefamandole against Bacteroides fragilis.
    McAllister TA
    Scand J Infect Dis Suppl; 1980; suppl 25():32-6. PubMed ID: 6937949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteroides fragilis bacteremias: clinical and evolutive features about 33 cases (author's transl)].
    Cadoz M; Beucler A; Dublanchet A; Richard A; Deborne B; Lafaix C
    Nouv Presse Med; 1978 Jun; 7(23):2045-8. PubMed ID: 673771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro sensitivity tests and in-vivo efficacy of cephalosporins against Bacteroides fragilis.
    Brook I
    J Antimicrob Chemother; 1990 Jul; 26(1):158-61. PubMed ID: 2211440
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.
    Griffith RS; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1977 May; 11(5):813-6. PubMed ID: 879736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of serious anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Scand J Infect Dis Suppl; 1980; suppl 25():84-8. PubMed ID: 7010541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bactericidal activities and morphologic changes in Escherichia coli and Bacteroides fragilis by cephalosporins.
    Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Satoh M; Kai J; Tamaya T
    Chemotherapy; 1998; 44(3):157-63. PubMed ID: 9612605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefamandole therapy of endomyometritis following cesarean section.
    Gibbs RS; Huff RW
    Am J Obstet Gynecol; 1980 Jan; 136(1):32-7. PubMed ID: 7352484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteroides fragilis septicemia. Incidence and sensitivity of the strains to antibiotics].
    Schoutens E; Labbé M; Yourassowsky E
    Pathol Biol (Paris); 1973 Apr; 21(4):349-53. PubMed ID: 4576172
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to cefamandole: a collaborative study of emerging clinical problems.
    Sanders CC; Moellering RC; Martin RR; Perkins RL; Strike DG; Gootz TD; Sanders WE
    J Infect Dis; 1982 Jan; 145(1):118-25. PubMed ID: 6274965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cephazolin and other cephalosporins against Bacteroides fragilis.
    Leigh DA; Simmons K
    Scott Med J; 1976 Sep; 20(5):228-31. PubMed ID: 1265472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteroides fragilis resistant to the administration of clindamycin.
    Salaki JS; Black R; Tally FP; Kislak JW
    Am J Med; 1976 Mar; 60(3):426-8. PubMed ID: 1258888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteroides fragilis septicemia during rheumatoid arthritis].
    Guidet M; Gallinet E; Metzger JM; Dupont MJ; Michel-Briand Y
    Nouv Presse Med; 1977 Sep; 6(29):2604-5. PubMed ID: 909745
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefamandole--effectiveness against anaerobes: supplementary remarks.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():94-5. PubMed ID: 7010543
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapeutic aspects of anaerobic septicemia.
    Stille W
    Infection; 1980; 8 Suppl 2():S191-2. PubMed ID: 7450862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteroides fragilis septicemia].
    Blache JL; Gouin F; Peloux Y; Charrel CT
    Ann Anesthesiol Fr; 1977; 18(10):848-52. PubMed ID: 23026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteroides fragilis meningitis in a premature infant successfully treated with metronidazole.
    Webber SA; Tuohy P
    Pediatr Infect Dis J; 1988 Dec; 7(12):886-7. PubMed ID: 3211633
    [No Abstract]   [Full Text] [Related]  

  • 20. Perforated and gangrenous appendicitis: an analysis of antibiotic failures.
    Heseltine PN; Yellin AE; Appleman MD; Gill MA; Chenella FC; Kern JW; Berne TV
    J Infect Dis; 1983 Aug; 148(2):322-9. PubMed ID: 6224864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.